Opioid abuse and dependence: Treatment review and future options; Focus on dronedarone for atrial fibrillation; Agents in late-stage development for pulmonary diseases.
Medicare’s Drug Price Negotiations Could Impact Physician Reimbursement
September 19th 2024When CMS begins negotiations for physician-administered drugs under the Inflation Reduction Act, providers, including those whose services are covered by commercial insurance, could see lowered reimbursement.
Read More